Generate Biomedicines

GENBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.840 B

$14.35 +3.31%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

128,352,436

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#119Bicara TherapeuticsBCAX$1.84B
#120Damora TherapeuticsDMRA$1.84B
#121Generate BiomedicinesGENB$1.84B
#122Syndax PharmaceuticalsSNDX$1.82B
#123KardiganKARD$1.80B

Where these numbers come from

Share counts and financials for Generate Biomedicines are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.